Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 60760-836

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 60760-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

836-30 (Venlafaxine 60760 836 30)

This text appears to be a medication label for Venlafaxine Hydrochloride extended-release capsules. The capsules contain 37.5mg of the active ingredient and come in a pack of 30 capsules. The NDC number for this product is 60760-836-30, and it is manufactured by Aurobindo Pharma USA, Inc. It is important to use this medication as directed and store it at a controlled room temperature between 15°C to 30°C (59°F to 86°F).*

FDA Label Image

Figure (Venlafaxine Fig1)

This text appears to be a list of special population considerations related to hepatic and renal impairment, CYP206 polymorphism, age, gender, and specific analyte named "velatarine." The inclusion of details such as mild to moderate impairment levels, hemodialysis for renal impairment, genetic polymorphism, and age and gender categories suggests a focus on tailoring treatments or interventions based on these factors. The mention of "Fold Change and 90% CI" implies some form of statistical analysis or data interpretation related to the analyte's effects.*

FDA Label Image

Figure (Venlafaxine Fig2)

This text appears to show a list of drugs and their interactions, specifically mentioning Enanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, and Lithium. It also references PK Fold Change and 90% CI. The text seems to provide information related to the change in values of these drugs in comparison to a reference value.*

FDA Label Image

Figure (Venlafaxine Fig3)

This document appears to list various drugs and interacting substances, along with their analytes, PK parameters like Cmax and AU, and fold change with 90% confidence intervals. It provides information on potential drug interactions involving ethanol, aprazolam, indinavir, metoprolol, risperidone, haloperidol, caffeine, tolbutamide, and lithium. The text suggests the study or documentation of specific drug levels in the body when interacting with other medications.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.